Occupe actuellement un poste chez Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Scientific Officer | Syndax Pharmaceuticals Inc | 1 septembre 2016 - |
Chief Technology Officer | Syndax Pharmaceuticals Inc | 1 novembre 2013 - 1 septembre 2016 |
Vice President of Translational Medicine, Founder | Syndax Pharmaceuticals Inc | 1 janvier 2012 - 1 octobre 2013 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-02-17 | 2023-02-15 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
17 428
-100.0%
25,84450 404 USD |
17 428 -100.0% | 25,84 | 450 404 USD | |
2023-02-17 | 2023-02-15 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
7 572
-100.0%
25,84195 688 USD |
7 572 -100.0% | 25,84 | 195 688 USD | |
2023-02-03 | 2023-02-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
69
-100.0%
28,431 962 USD |
69 -100.0% | 28,43 | 1 962 USD | |
2022-12-02 | 2022-12-02 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
17 200
-98.5%
25,05430 936 USD |
17 200 -98.5% | 25,05 | 430 936 USD | |
2022-12-02 | 2022-12-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
4 028
-93.8%
25,01100 746 USD |
4 028 -93.8% | 25,01 | 100 746 USD | |
2022-12-02 | 2022-12-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
3 772
-93.4%
25,0194 343 USD |
3 772 -93.4% | 25,01 | 94 343 USD | |
2022-08-26 | 2022-08-24 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
2 154
-89.0%
25,0453 927 USD |
2 154 -89.0% | 25,04 | 53 927 USD | |
2022-08-26 | 2022-08-24 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
22 846
-98.9%
25,04571 966 USD |
22 846 -98.9% | 25,04 | 571 966 USD | |
2022-02-03 | 2022-02-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
1 412
-100.0%
16,6523 510 USD |
1 412 -100.0% | 16,65 | 23 510 USD | |
2020-11-25 | 2020-11-23 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
16 334
-100.0%
22,89373 924 USD |
16 334 -100.0% | 22,89 | 373 924 USD | |
2020-11-25 | 2020-11-23 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
7 954
-32.7%
23,58187 594 USD |
7 954 -32.7% | 23,58 | 187 594 USD | |
2020-11-25 | 2020-11-23 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
5 684
-19.0%
23,33132 603 USD |
5 684 -19.0% | 23,33 | 132 603 USD |